(2H5)Aniline
(2H5)Aniline structure
|
Common Name | (2H5)Aniline | ||
|---|---|---|---|---|
| CAS Number | 4165-61-1 | Molecular Weight | 98.157 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 184.4±0.0 °C at 760 mmHg | |
| Molecular Formula | C6H2D5N | Melting Point | -6ºC(lit.) | |
| MSDS | Chinese USA | Flash Point | 70.0±0.0 °C | |
| Symbol |
GHS06, GHS08, GHS09 |
Signal Word | Danger | |
| Name | 2,3,4,5,6-pentadeuterioaniline |
|---|---|
| Synonym | More Synonyms |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 184.4±0.0 °C at 760 mmHg |
| Melting Point | -6ºC(lit.) |
| Molecular Formula | C6H2D5N |
| Molecular Weight | 98.157 |
| Flash Point | 70.0±0.0 °C |
| Exact Mass | 98.089233 |
| PSA | 26.02000 |
| LogP | 0.94 |
| Appearance of Characters | Liquid | Clear orange to yellow-brown |
| Vapour density | 3.22 (184 °C, vs air) |
| Vapour Pressure | 0.7±0.3 mmHg at 25°C |
| Index of Refraction | 1.579 |
| Storage condition | 2-8°C |
| Symbol |
GHS06, GHS08, GHS09 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 + H311 + H331-H341-H351-H410 |
| Precautionary Statements | P261-P273-P280-P301 + P310-P311-P501 |
| Target Organs | Blood, Central nervous system, Liver |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | T,N |
| Risk Phrases | R20/21/22;R40;R48/23/24/25;R50 |
| Safety Phrases | S28-S36/37-S45-S61 |
| RIDADR | UN 1547 6.1/PG 2 |
| WGK Germany | 3 |
| Hazard Class | 6.1 |
|
~98%
(2H5)Aniline CAS#:4165-61-1 |
| Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 53, # 3 p. 148 - 152 |
|
~%
(2H5)Aniline CAS#:4165-61-1 |
| Literature: Journal of the American Chemical Society, , vol. 134, # 22 p. 9098 - 9101 |
|
~64%
(2H5)Aniline CAS#:4165-61-1 |
| Literature: Bulletin of the Chemical Society of Japan, , vol. 81, # 2 p. 278 - 286 |
|
~%
(2H5)Aniline CAS#:4165-61-1 |
| Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 41, # 12 p. 1103 - 1126 |
|
~%
(2H5)Aniline CAS#:4165-61-1 |
| Literature: Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy, , vol. 38, # 8 p. 903 - 912 |
|
~%
(2H5)Aniline CAS#:4165-61-1 |
| Literature: Chemische Berichte, , vol. 118, # 5 p. 1782 - 1797 |
| Precursor 4 | |
|---|---|
| DownStream 9 | |
![N-[4-(4-acetamido-2,3,5,6-tetradeuteriophenyl)sulfonyl-2,3,5,6-tetradeuteriophenyl]acetamide structure](https://image.chemsrc.com/caspic/272/557794-37-3.png)
CAS#:557794-37-3
CAS#:557794-38-4
CAS#:37055-51-9
CAS#:635-46-1
CAS#:4375-15-9
CAS#:612-96-4![2-Methyl-2-propanyl [6-(2-{2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(2H5)phenylcarbamoyl]-1H-pyrrol-1-yl}ethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate structure](https://image.chemsrc.com/caspic/038/265989-34-2.png)
CAS#:265989-34-2
CAS#:265989-32-0
CAS#:1211-35-4|
Ionization suppression effects with condensed phase membrane introduction mass spectrometry: methods to increase the linear dynamic range and sensitivity.
J. Mass Spectrom. 50(3) , 437-43, (2015) Condensed phase membrane introduction mass spectrometry (CP-MIMS) is an online analytical method that allows for the direct, trace level measurement of a wide range of analytes in complex samples. The... |
| Phenyl-d5-amine |
| Benzen-d5-amine |
| MFCD00044420 |
| EINECS 224-015-9 |
| (H)Aniline |
| Aniline-2,3,4,5,6-d5 |
| 2,3,4,5,6-pentadeuterio-aniline |
| Benzen-d-amine |
| Aniline-d5 |